Epigral has launched its first research and development centre at Ahmedabad, Gujarat. This is a significant step for the company in enhancing its research capabilities and accelerating its journey towards building Specialty products. The centre has been developed with an initial investment of Rs 30 crore and the company will further invest to enhance its capability as its proceeds further.
Located at Changodar in Ahmedabad, the R&D centre is built over 14,374 sq. mt and has the latest, state-of-the-art technologies installed that will enable Epigral to catalyse identification of specialty chemical molecules for later introduction in India. The company has consciously strived towards creating a key differentiator for itself by graduating from being a chemical manufacturer to developing research-driven products, in-house.
Epigral, formerly known as Meghmani Finechem, is a leading integrated manufacturer of chemicals in India.
